Advancing mitochondrial medicine
About Santhera

About


Santhera


We are a Swiss specialty pharmaceutical company committed to developing medicines to meet the needs of patients living with mitochondrial disorders and other rare diseases.
________

Read more >>

PATIENTS


About mitochondrial diseases


At Santhera, we are passionate about providing treatment options for patients with rare mitochondrial diseases, specifically in the area of neuromuscular and neuro-ophthalmological conditions – diseases that have a severe impact on the lives of affected children and adults.
________

Read more >>
home-picture-01
Our medicines

Health Care Professionals


Our medicines



Our focus is on the development of treatments for neuromuscular and neuro-ophthalmological diseases that currently lack treatment options. In September 2015, we received our first European Marketing Authorization for Raxone® in the treatment of patients with Leber’s hereditary optic neuropathy.

________

Read more >>

Investors & Media


Tools and Resources



The Investor and Media center provides information and resources for investor and media communities.

________

Read more >>
Tools and Resources
Working at Santhera

Career


Working @Santhera



Santhera is a dynamic and international employer looking for colleagues who are talented, engaged and committed to growing the organization through the work that they do.

________

Read more >>

Join our Feeds

news

Latest News

June 21, 2016
Santhera’s Marketing Authorization Application for Raxone® in Duchenne Muscular Dystrophy (DMD) Validated by the European Medicines Agency 
Read morepdf-icon


June 1, 2016
New Data from Santhera’s Phase III Trial (DELOS) in Duchenne Muscular Dystrophy (DMD) in Neuromuscular Disorders 
Read morepdf-icon


May 31, 2016
Santhera Files Marketing Authorization Application in the European Union for Raxone® for the Treatment of Duchenne Muscular Dystrophy (DMD)
Read morepdf-icon


To subscribe to our News Feed, please click here.

facebook

Facebook

linkedin

Linked In

This section of the website is intended to provide healthcare professionals with information about Raxone® and other products in Santhera’s pipeline. I am a healthcare professional I am not a healthcare professional